葡萄糖酸钙原料药垄断

Why it is here

State Administration for Market Regulation of China — antitrust (SAMR and provincial AMRs, samr.gov.cn) — cartel (monopoly agreement) (国家市场监督管理总局 · 国市监处〔2020〕8号 · 市场监管总局发布葡萄糖酸钙原料药垄断案行政处罚决定书), from 14 April 2020.

State Administration for Market Regulation of China — antitrust (SAMR and provincial AMRs, samr.gov.cn) — Cartel (monopoly agreement).

Details

Company

葡萄糖酸钙原料药垄断

Authority

State Administration for Market Regulation of China — antitrust (SAMR and provincial AMRs, samr.gov.cn)

Decision

Cartel (monopoly agreement)

Grounds and details, as published

国家市场监督管理总局 · 国市监处〔2020〕8号 · 市场监管总局发布葡萄糖酸钙原料药垄断案行政处罚决定书

From

14 April 2020

Until

—

Status

End date not published

Source

https://www.samr.gov.cn/fldys/tzgg/xzcf/art/2023/art_eff3f1fb0ed04911a2e66e238be54f95.html

Licence

Public antitrust decisions published by the State Administration for Market Regulation of China (samr.gov.cn/fldys)